PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM

OMIM Update List for May, 2009

Please send your questions to the NCBI Help Desk.

May 29, 2009

New Entries:

612837 COQ9, S. CEREVISIAE, HOMOLOG OF; COQ9

Changed Entries:

113500 BRACHYOLMIA TYPE 3
125240 CD55 ANTIGEN; CD55
137360 GENOCHONDROMATOSIS
146660 INTERLEUKIN 7; IL7
156530 METATROPIC DYSPLASIA
156550 KNIEST DYSPLASIA
176680 MOVED TO 142880
184252 SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK
185470 SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT B, IRON SULFUR PROTEIN; SDHB
187600 THANATOPHORIC DYSPLASIA, TYPE I; TD1
192240 VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF
194460 ALPHA-2-GLYCOPROTEIN, ZINC; AZGP1
218340 CRANIOFACIAL DYSMORPHISM WITH OCULAR COLOBOMA, ABSENT CORPUS CALLOSUM,
242900 IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE
250600 MOVED TO 156530
261600 PHENYLKETONURIA; PKU
300017 FILAMIN A; FLNA
300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT
300321 FG SYNDROME 2; FGS2
304110 CRANIOFRONTONASAL SYNDROME; CFNS
305450 OPITZ-KAVEGGIA SYNDROME; OKS
600133 LAMININ, ALPHA-4; LAMA4
600527 EPHRIN B2; EFNB2
601011 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A
601033 LAMININ, ALPHA-5; LAMA5
601808 CHROMOSOME 18q DELETION SYNDROME
601937 NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3
603020 ATPase FAMILY GENE 3-LIKE 1; AFG3L1
603149 INTERLEUKIN 17A; IL17A
604499 HYPERLIPIDEMIA, COMBINED, 2
604856 LANGERHANS CELL HISTIOCYTOSIS
605427 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4;
606598 GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1
607426 COENZYME Q10 DEFICIENCY
607790 TET ONCOGENE 1; TET1
607872 CHROMOSOME 1p36 DELETION SYNDROME
612349 PHENYLALANINE HYDROXYLASE; PAH
612834 PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1; PHLDB1
612837 COQ9, S. CEREVISIAE, HOMOLOG OF; COQ9
Clinical Synopsis for 115310 PARAGANGLIOMAS 4; PGL4

May 28, 2009

New Entries:

612823 TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D; TAF1D
612824 SEC14-LIKE 3; SEC14L3
612825 SEC14-LIKE 4; SEC14L4
612826 SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 1; SGPP1
612827 SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 2; SGPP2
612828 CCAAT/ENHANCER-BINDING PROTEIN, ZETA; CEBPZ
612829 RAS-ASSOCIATED PROTEIN RAB3C; RAB3C
612830 SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 3; DHRS3
612831 17-@BETA-HYDROXYSTEROID DEHYDROGENASE XI; HSD17B11
612832 17-@BETA-HYDROXYSTEROID DEHYDROGENASE XIV; HSD17B14
612833 SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7; DHRS7
612834 PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1; PHLDB1
Clinical Synopsis for 612776 HYPOGLOSSIA WITH SITUS INVERSUS
Clinical Synopsis for 612782 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT
Clinical Synopsis for 612798 QUESTION MARK EARS, ISOLATED

Changed Entries:

125265 RECEPTOR EXPRESSION-ENHANCING PROTEIN 5; REEP5
142800 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A
142850 MOVED TO 142860
142857 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1
142858 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1; HLA-DPB1
142860 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA
142880 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1
146880 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1
157860 MOVED TO 142860
176680 MOVED TO 142880
300096 TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 2; TM4SF2
300210 MENTAL RETARDATION, X-LINKED 58; MRX58
601045 CATENIN, DELTA-1; CTNND1
601804 TRANSCRIPTION FACTOR Sp3; SP3
601922 ANGIOPOIETIN 2; ANGPT2
601937 NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3
602680 RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5
602942 ECOTROPIC VIRAL INTEGRATION SITE 5; EVI5
603599 CASP8- AND FADD-LIKE APOPTOSIS REGULATOR; CFLAR
604475 RETICULON 4; RTN4
604672 CD209 ANTIGEN; CD209
605101 MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7-INTERACTING PROTEIN
605129 PROTEASOME ACTIVATOR SUBUNIT 3; PSME3
606013 F-BOX ONLY PROTEIN 5; FBXO5
606409 ITCHY, MOUSE, HOMOLOG OF; ITCH
606787 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1
607558 SEC14-LIKE 2; SEC14L2
607776 SIN3, YEAST, HOMOLOG OF, A; SIN3A
609669 WD REPEAT-CONTAINING PROTEIN 36; WDR36
611532 NUCLEOLAR PROTEIN 6; NOL6
611998 cAMP RESPONSIVE ELEMENT-BINDING PROTEIN 3-LIKE 3; CREB3L3
612052 LUNG CANCER SUSCEPTIBILITY 2; LNCR2
612127 17-@BETA-HYDROXYSTEROID DEHYDROGENASE XIII; HSD17B13
612798 QUESTION MARK EARS, ISOLATED
Clinical Synopsis for 100300 ADAMS-OLIVER SYNDROME; AOS
Clinical Synopsis for 602629 DYSTONIA 6, TORSION; DYT6
Clinical Synopsis for 610765 ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE

May 28, 2009

New Entries:

612806 G PROTEIN-COUPLED RECEPTOR 89B; GPR89B
612816 UTP18, S. CEREVISIAE, HOMOLOG OF; UTP18
612817 KRR1, YEAST, HOMOLOG OF; KRR1
612818 NUCLEOLAR AND SPINDLE-ASSOCIATED PROTEIN 1; NUSAP1
612819 NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 4, S. CEREVISIAE, HOMOLOG OF;
612820 NEUROPLASTIN; NPTN
612821 G PROTEIN-COUPLED RECEPTOR 89A; GPR89A
612822 UTP20, S. CEREVISIAE, HOMOLOG OF; UTP20
Clinical Synopsis for 612379 COLOBOMA, OCULAR, AND ICHTHYOSIS, BRAIN MALFORMATIONS, AND ENDOCRINE

Changed Entries:

102200 PITUITARY ADENOMA, GROWTH HORMONE-SECRETING
106180 ANGIOTENSIN I-CONVERTING ENZYME; ACE
114760 CARBONIC ANHYDRASE IV; CA4
117800 EAR WAX, WET/DRY
120500 COMMISSURAL LIP PITS
125520 CAYLER CARDIOFACIAL SYNDROME
125570 DERMATOGLYPHICS--ARCH ON ANY DIGIT
142800 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A
158105 CHEMOKINE, CC MOTIF, LIGAND 2; CCL2
159900 MYOCLONIC DYSTONIA
162400 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I; HSAN1
171790 PHOSPHATASE, PROSTATE-SPECIFIC ACID; ACPP
177050 PROTRUSIO ACETABULI
180710 SMALL NUCLEOLAR RNA, C/D BOX, 3A; SNORD3A
185900 SYNDACTYLY, TYPE I
193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4
236670 WALKER-WARBURG SYNDROME; WWS
276400 TWINNING, DIZYGOTIC
300005 METHYL-CpG-BINDING PROTEIN 2; MECP2
300041 GUANYLATE CYCLASE 2F, RETINAL; GUCY2F
300531 SPROUTY, DROSOPHILA, HOMOLOG OF, 3; SPRY3
309900 MUCOPOLYSACCHARIDOSIS TYPE II
600179 GUANYLATE CYCLASE 2D, MEMBRANE; GUCY2D
600275 NOTCH, DROSOPHILA, HOMOLOG OF, 2; NOTCH2
601138 GUANYLATE CYCLASE 2E; GUCY2E
601543 DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12
601843 SOLUTE CARRIER FAMILY 5 (SODIUM IODIDE SYMPORTER), MEMBER 5; SLC5A5
602465 SPROUTY, DROSOPHILA, HOMOLOG OF, 1; SPRY1
602466 SPROUTY, DROSOPHILA, HOMOLOG OF, 2; SPRY2
602561 BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS
602661 TUBULIN, BETA-3; TUBB3
604124 RETINOBLASTOMA-BINDING PROTEIN 8; RBBP8
605204 TORSIN-A; DYT1
605209 CHECKPOINT PROTEIN WITH FHA AND RING FINGER DOMAINS; CHFR
605712 SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 1; SPTLC1
606149 FATTY ACID DESATURASE 2; FADS2
606681 NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX
607301 PRECURSOR mRNA-PROCESSING FACTOR 3, S. CEREVISIAE, HOMOLOG OF; PRPF3
607948 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO
607984 SPROUTY, DROSOPHILA, HOMOLOG OF, 4; SPRY4
608372 DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49
609007 LEUCINE-RICH REPEAT KINASE 2; LRRK2
611913 AUTISM, SUSCEPTIBILITY TO, 14; AUTS14
612379 COLOBOMA, OCULAR, AND ICHTHYOSIS, BRAIN MALFORMATIONS, AND ENDOCRINE
612790 RGNEF, MOUSE, HOMOLOG OF
612791 ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 3; ZKSCAN3
612792 PHOSPHATIDYLSERINE SYNTHASE 1; PTDSS1
612793 PHOSPHATIDYLSERINE SYNTHASE 2; PTDSS2
Clinical Synopsis for 164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD
Clinical Synopsis for 272800 TAY-SACHS DISEASE; TSD
Clinical Synopsis for 600142 CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS

May 26, 2009

New Entries:

612807 LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN
612808 LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN
612809 LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN
612810 LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN
612811 LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN
612812 PROFILIN 3; PFN3
612813 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE
612814 SPERMATOGENESIS-ASSOCIATED PROTEIN 18; SPATA18
612815 ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 13; ZDHHC13

Changed Entries:

108960 NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A; NPR1
121014 GAP JUNCTION PROTEIN, ALPHA-1; GJA1
155760 AGGRECAN; ACAN
164200 OCULODENTODIGITAL DYSPLASIA; ODDD
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS
253010 MORQUIO SYNDROME B
257850 OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE
300041 GUANYLATE CYCLASE 2F, RETINAL; GUCY2F
600179 GUANYLATE CYCLASE 2D, MEMBRANE; GUCY2D
600783 HISTIDYL-tRNA SYNTHETASE 2; HARS2
601137 MOVED TO 601138
601138 GUANYLATE CYCLASE 2E; GUCY2E
604544 LEUCYL-tRNA SYNTHETASE 2; LARS2
604733 TRYPTOPHANYL-tRNA SYNTHETASE 2; WARS2
607799 ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 17; ZDHHC17
609728 METHIONYL-tRNA SYNTHETASE 2; MARS2
610956 ASPARTYL-tRNA SYNTHETASE 2; DARS2
610957 TYROSYL-tRNA SYNTHETASE 2; YARS2
611592 PHENYLALANYL-tRNA SYNTHETASE 2, MITOCHONDRIAL; FARS2

May 22, 2009

New Entries:

612798 QUESTION MARK EARS, ISOLATED
612799 GLUTAMYL-tRNA SYNTHETASE 2; EARS2
612800 CYSTEINYL-tRNA SYNTHETASE 2; CARS2
612801 ISOLEUCYL-tRNA SYNTHETASE 2; IARS2
612802 VALYL-tRNA SYNTHETASE 2; VARS2
612803 ASPARAGINYL-tRNA SYNTHETASE 2; NARS2
612804 SERYL-tRNA SYNTHETASE 2; SARS2
612805 THREONYL-tRNA SYNTHETASE 2; TARS2

Changed Entries:

100800 ACHONDROPLASIA; ACH
141800 HEMOGLOBIN--ALPHA LOCUS 1; HBA1
141900 HEMOGLOBIN--BETA LOCUS; HBB
147440 INSULIN-LIKE GROWTH FACTOR I; IGF1
151670 LIPASE, HEPATIC; LIPC
164761 REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET
200700 CHONDRODYSPLASIA, GREBE TYPE
602483 AURICULOCONDYLAR SYNDROME
605225 INFLAMMATORY BOWEL DISEASE 7; IBD7
608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY
612782 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT
612785 MEGARBANE-JALKH SYNDROME
612797 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
612800 CYSTEINYL-tRNA SYNTHETASE 2; CARS2

May 21, 2009

New Entries:

612796 INFLAMMATORY BOWEL DISEASE 27; IBD27
612797 INFLAMMATORY BOWEL DISEASE 28; IBD28

Changed Entries:

107000 ANONYCHIA-ONYCHODYSTROPHY
111150 BLOOD GROUP--LUTHERAN INHIBITOR; INLU
119800 CLUBFOOT, CONGENITAL; CCF
119900 DIGITAL CLUBBING, ISOLATED CONGENITAL
126200 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
134797 FIBRILLIN 1; FBN1
139100 GRAYING OF HAIR, PRECOCIOUS
142800 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A
142880 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1
146110 HYPOGONADOTROPIC HYPOGONADISM
147791 JACOBSEN SYNDROME; JBS
178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1
186855 T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 2; TAL2
191190 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A; TNFRSF1A
256800 INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA
260400 SHWACHMAN-DIAMOND SYNDROME; SDS
261800 PIERRE ROBIN SYNDROME
300592 CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A11; CT47A11
602629 DYSTONIA 6, TORSION; DYT6
603599 CASP8- AND FADD-LIKE APOPTOSIS REGULATOR; CFLAR
603711 CYTOCHROME P450, FAMILY 7, SUBFAMILY B, POLYPEPTIDE 1; CYP7B1
606365 GLUTAMINASE, LIVER; GLS2
607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21
607924 METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MALAT1
609139 RECEPTOR EXPRESSION-ENHANCING PROTEIN 1; REEP1
609678 SLIT- AND NTRK-LIKE FAMILY, MEMBER 1; SLITRK1
609706 DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31
610569 UBIQUITIN-SPECIFIC PROTEASE 24; USP24
611058 PEROXISOME BIOGENESIS FACTOR 5-LIKE; PEX5L
611114 MICRO RNA 150; MIR150
611170 STERILE ALPHA MOTIF DOMAIN-CONTAINING 9-LIKE; SAMD9L
611904 CHROMOSOME 11 OPEN READING FRAME 34; C11ORF34
612740 PORPHYRIA, ACUTE HEPATIC
612759 SYNESTHESIA
612768 FOLLICULIN-INTERACTING PROTEIN 2; FNIP2
612769 NONCODING RNA 84; NCRNA00084
612770 PHOSPHATIDYLSERINE DECARBOXYLASE; PISD
612771 DUAL OXIDASE MATURATION FACTOR 1; DUOXA1
612772 DUAL OXIDASE MATURATION FACTOR 2; DUOXA2
612778 SET DOMAIN-CONTAINING PROTEIN 2; SETD2
612779 DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD
612780 SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND
612782 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT
612783 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT
612784 HUNTINGTIN-INTERACTING PROTEIN K
612786 CYCLIN Y; CCNY
612787 PSEUDOURIDYLATE SYNTHASE 10; PUS10
612788 FORKHEAD BOX Q1; FOXQ1
612797 INFLAMMATORY BOWEL DISEASE 28; IBD28
Clinical Synopsis for 605472 USHER SYNDROME, TYPE IIC; USH2C

May 20, 2009

New Entries:

612794 ATRIAL SEPTAL DEFECT 5; ASD5

Changed Entries:

100100 ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND
102540 ACTIN, ALPHA, CARDIAC MUSCLE; ACTC1
106180 ANGIOTENSIN I-CONVERTING ENZYME; ACE
108800 ATRIAL SEPTAL DEFECT 1; ASD1
121014 GAP JUNCTION PROTEIN, ALPHA-1; GJA1
139210 GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE
158000 MONILETHRIX
164200 OCULODENTODIGITAL DYSPLASIA; ODDD
180069 RETINAL PIGMENT EPITHELIUM-SPECIFIC PROTEIN, 65-KD; RPE65
186100 SYNDACTYLY, TYPE III
192445 VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE
204200 CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
256700 NEUROBLASTOMA
257850 OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE
306700 HEMOPHILIA A
600599 KRUPPEL-LIKE FACTOR 1; KLF1
600795 FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3
601452 OCULOAURICULOFRONTONASAL SYNDROME; OAFNS
601928 KERATIN 86; KRT86
602942 ECOTROPIC VIRAL INTEGRATION SITE 5; EVI5
607042 CLN3 GENE; CLN3
607941 ATRIAL SEPTAL DEFECT 2; ASD2
609512 CHMP FAMILY, MEMBER 2B; CHMP2B
611363 ATRIAL SEPTAL DEFECT 4; ASD4
612740 PORPHYRIA, ACUTE HEPATIC
612793 PHOSPHATIDYLSERINE SYNTHASE 2; PTDSS2
612794 ATRIAL SEPTAL DEFECT 5; ASD5

May 19, 2009

New Entries:

612790 RGNEF, MOUSE, HOMOLOG OF
612791 ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 3; ZKSCAN3
612792 PHOSPHATIDYLSERINE SYNTHASE 1; PTDSS1
612793 PHOSPHATIDYLSERINE SYNTHASE 2; PTDSS2
Clinical Synopsis for 605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED

Changed Entries:

103780 ALCOHOL DEPENDENCE
104311 PRESENILIN 1; PSEN1
119900 DIGITAL CLUBBING, ISOLATED CONGENITAL
127000 KENNY-CAFFEY SYNDROME, TYPE 2
146510 PALLISTER-HALL SYNDROME; PHS
147545 INSULIN RECEPTOR SUBSTRATE 1; IRS1
147557 INTEGRIN, BETA-4; ITGB4
151600 LEUKONYCHIA TOTALIS
162280 NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE; NEFL
164200 OCULODENTODIGITAL DYSPLASIA; ODDD
173391 PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE; PLAUR
186100 SYNDACTYLY, TYPE III
192350 VATER ASSOCIATION
215700 CITRULLINEMIA, CLASSIC
244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1
245349 PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY
257850 OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE
261800 PIERRE ROBIN SYNDROME
305645 MOVED TO 136760
600086 ALCOHOL DEHYDROGENASE 7; ADH7
602253 KRUPPEL-LIKE FACTOR 4; KLF4
603470 ARGININOSUCCINATE SYNTHETASE; ASS
605046 UBIQUILIN 1; UBQLN1
605704 VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN B; VAPB
605921 STROMAL INTERACTION MOLECULE 1; STIM1
606667 LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5; LGR5
608576 GRAINYHEAD-LIKE 2; GRHL2
608582 EPIDERMAL GROWTH FACTOR-LIKE 7; EGFL7
608641 DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28
609065 MOVED TO 605714
610277 TRANSMEMBRANE PROTEIN 142A; TMEM142A
611643 ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 4; ZKSCAN4
611767 MICRO RNA 126; MIR126
612448 AGE-RELATED HEARING IMPAIRMENT 1; ARHI1
612792 PHOSPHATIDYLSERINE SYNTHASE 1; PTDSS1
Clinical Synopsis for 241410 HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD
Clinical Synopsis for 305645 MOVED TO 136760
Clinical Synopsis for 601808 CHROMOSOME 18q DELETION SYNDROME
Clinical Synopsis for 608641 DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28
Clinical Synopsis for 609065 MOVED TO 605714

May 18, 2009

New Entries:

612740 PORPHYRIA, ACUTE HEPATIC
612776 HYPOGLOSSIA WITH SITUS INVERSUS
612777 HYPOTONIA, SEIZURES, AND PRECOCIOUS PUBERTY
612780 SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND
612782 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT
612783 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT

Changed Entries:

103300 HYPOGLOSSIA-HYPODACTYLIA
103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A
107470 INTERFERON, GAMMA, RECEPTOR 1; IFNGR1
119900 DIGITAL CLUBBING, ISOLATED CONGENITAL
125270 DELTA-AMINOLEVULINATE DEHYDRATASE; ALAD
127000 KENNY-CAFFEY SYNDROME, TYPE 2
143890 HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT
147570 INTERFERON, GAMMA; IFNG
167100 HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT
171000 PEYRONIE DISEASE
179613 RECOMBINANT CHROMOSOME 8 SYNDROME
181750 SCLERODERMA, FAMILIAL PROGRESSIVE
189990 V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG; MYB
219150 CUTIS LAXA, CORNEAL CLOUDING, AND MENTAL RETARDATION
255980 NASODIGITOACOUSTIC SYNDROME
266265 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C
274270 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY
300592 CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A11; CT47A11
313650 TAF1 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR,
600492 NUCLEAR FACTOR ERYTHROID 2-LIKE 2; NFE2L2
601688 15-@HYDROXYPROSTAGLANDIN DEHYDROGENASE; HPGD
601742 TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TRIM28
602208 POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10; KCNJ10
603233 PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B
603377 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5
605881 SOLUTE CARRIER FAMILY 35, MEMBER C1; SLC35C1
605921 STROMAL INTERACTION MOLECULE 1; STIM1
606576 TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR,
606945 LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR
607948 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO
610277 TRANSMEMBRANE PROTEIN 142A; TMEM142A
611114 MICRO RNA 150; MIR150
612732 COPROPORPHYRINOGEN OXIDASE; CPOX
612777 HYPOTONIA, SEIZURES, AND PRECOCIOUS PUBERTY
612779 DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD
612782 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT
612783 IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT
Clinical Synopsis for 603233 PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B

May 15, 2009

New Entries:

612779 DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD
612786 CYCLIN Y; CCNY
612787 PSEUDOURIDYLATE SYNTHASE 10; PUS10
612788 FORKHEAD BOX Q1; FOXQ1

Changed Entries:

107450 INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 1; IFNAR1
134370 COMPLEMENT FACTOR H; CFH
147583 INTERFERON, ALPHA-17; IFNA17
155555 MELANOCORTIN 1 RECEPTOR; MC1R
163729 NITRIC OXIDE SYNTHASE 3; NOS3
212140 CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP
220210 DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2
274270 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY
278850 XX MALE SYNDROME
600541 ETS VARIANT GENE 1; ETV1
601090 FORKHEAD BOX C1; FOXC1
602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3
602628 FORKHEAD BOX N3; FOXN3
602925 PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA; PIK3CB
603055 SKI-INTERACTING PROTEIN; SKIIP
603377 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5
603504 CELL DIVISION CYCLE 14, S. CEREVISIAE, HOMOLOG A; CDC14A
604970 AURORA KINASE B; AURKB
606611 DEFENSIN, BETA, 103A; DEFB103A
610051 CHMP FAMILY, MEMBER 4A; CHMP4A
610901 CHMP FAMILY, MEMBER 6; CHMP6
610966 FAT MASS- AND OBESITY-ASSOCIATED GENE; FTO
612205 AUTOPHAGY 9, S. CEREVISIAE, HOMOLOG OF, B; ATG9B

May 14, 2009

New Entries:

612785 MEGARBANE-JALKH SYNDROME
Clinical Synopsis for 612651 ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO

Changed Entries:

108961 NATRIURETIC PEPTIDE RECEPTOR B/GUANYLATE CYCLASE B; NPR2
126200 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
133170 ERYTHROPOIETIN; EPO
138248 GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1; GRIA1
147264 INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 75-KD; INPP5B
155555 MELANOCORTIN 1 RECEPTOR; MC1R
186930 T-CELL ANTIGEN RECEPTOR, BETA SUBUNIT; TCRB
201180 ACROFRONTOFACIONASAL DYSOSTOSIS 1
229400 FRONTOFACIONASAL DYSPLASIA
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2
261600 PHENYLKETONURIA; PKU
300394 TAFAZZIN; TAZ
600274 FRONTOTEMPORAL DEMENTIA; FTD
600716 PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22; PTPN22
600810 PHOSPHOLIPASE C, BETA-4; PLCB4
602382 PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC; PLD1
602739 PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-1; PRKAA1
603025 PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN; PICALM
603377 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5
603962 RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 1; RASGRP1
604479 SIRTUIN 1; SIRT1
604909 CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 2; CNOT2
605241 LYMPHOCYTE ANTIGEN 86; LY86
605613 HUNTINGTIN-INTERACTING PROTEIN 1-RELATED PROTEIN; HIP1R
605953 DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 1; DDEF1
606869 HEXOSAMINIDASE A; HEXA
607262 EPSIN 1; EPN1
607412 PALATE, LUNG, AND NASAL EPITHELIUM CARCINOMA-ASSOCIATED PROTEIN; PLUNC
608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY
609214 SEC61 COMPLEX, BETA SUBUNIT; SEC61B
609654 SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS
609758 Na+/K+ TRANSPORTING ATPase-INTERACTING PROTEIN 2; NKAIP2
611228 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J
611287 CORNICHON, DROSOPHILA, HOMOLOG OF; CNIH
611288 CORNICHON, DROSOPHILA, HOMOLOG OF, 2; CNIH2
612724 ALDOLASE B, FRUCTOSE-BISPHOSPHATE; ALDOB
Clinical Synopsis for 115300 HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT
Clinical Synopsis for 191160 TUMOR NECROSIS FACTOR; TNF
Clinical Synopsis for 205400 TANGIER DISEASE; TGD
Clinical Synopsis for 246700 CHYLOMICRON RETENTION DISEASE; CMRD
Clinical Synopsis for 256600 NEUROAXONAL DYSTROPHY, INFANTILE; INAD1
Clinical Synopsis for 259100 HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE
Clinical Synopsis for 263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION
Clinical Synopsis for 304050 AICARDI SYNDROME; AIC
Clinical Synopsis for 309000 LOWE OCULOCEREBRORENAL SYNDROME; OCRL
Clinical Synopsis for 602629 DYSTONIA 6, TORSION; DYT6
Clinical Synopsis for 607855 MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
Clinical Synopsis for 611603 LISSENCEPHALY 3; LIS3

May 13, 2009

New Entries:

612784 HUNTINGTIN-INTERACTING PROTEIN K
Clinical Synopsis for 603671 ACROMELIC FRONTONASAL DYSOSTOSIS

Changed Entries:

103500 TIETZ SYNDROME
115197 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
124092 INTERLEUKIN 10; IL10
136900 FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY; SFD
153337 LYMPHOCYTE ACTIVATION GENE 3; LAG3
156845 MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
167320 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL
167416 PAIRED BOX GENE 9; PAX9
181500 SCHIZOPHRENIA; SCZD
181510 SCHIZOPHRENIA 1; SCZD1
182330 ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1
186880 T-CELL ANTIGEN RECEPTOR, ALPHA SUBUNIT; TCRA
188826 TISSUE INHIBITOR OF METALLOPROTEINASE 3; TIMP3
189963 GENERAL TRANSCRIPTION FACTOR IIB; GTF2B
214800 CHARGE SYNDROME
219700 CYSTIC FIBROSIS; CF
229050 FOLATE MALABSORPTION, HEREDITARY
231300 GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A
300392 WAS GENE; WAS
300771 TRANSCRIPTION ELONGATION FACTOR A-LIKE 7; TCEAL7
300772 TRANSCRIPTION FACTOR DP FAMILY, MEMBER 3; TFDP3
300773 APEX NUCLEASE (APURINIC/APYRIMIDINIC ENDONUCLEASE) 2; APEX2
301000 WISKOTT-ALDRICH SYNDROME; WAS
600354 SURVIVAL OF MOTOR NEURON 1, TELOMERIC; SMN1
600726 INDIAN HEDGEHOG; IHH
600958 MYOSIN-BINDING PROTEIN C, CARDIAC; MYBPC3
601023 VALOSIN-CONTAINING PROTEIN; VCP
601081 ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2
601309 PATCHED, DROSOPHILA, HOMOLOG OF, 1; PTCH1
601767 HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
601771 CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1B1
601973 RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2
602208 POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10; KCNJ10
602390 HEMOCHROMATOSIS, JUVENILE; JH
602539 MITOGEN-ACTIVATED KINASE KINASE KINASE 3; MAP3K3
603030 TOLL-LIKE RECEPTOR 4; TLR4
603135 CULLIN 2; CUL2
603175 SCHIZOPHRENIA 5; SCZD5
603234 ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6; ABCC6
603502 INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1; IFRD1
603671 ACROMELIC FRONTONASAL DYSOSTOSIS
603790 SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 1; SLC23A1
603791 SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2; SLC23A2
604407 LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 1; LETM1
604625 TOOTH AGENESIS, SELECTIVE, 3; STHAG3
604906 SCHIZOPHRENIA 9; SCZD9
605243 LYMPHOCYTE ANTIGEN 96; LY96
605474 TOLL-LIKE RECEPTOR 9; TLR9
605597 FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2
606178 HEDGEHOG-INTERACTING PROTEIN; HHIP
606201 WFS1 GENE; WFS1
606576 TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR,
606797 SUPPRESSION OF TUMORIGENICITY 14; ST14
607060 PARKINSON DISEASE 8; PARK8
607239 DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33
607301 PRECURSOR mRNA-PROCESSING FACTOR 3, S. CEREVISIAE, HOMOLOG OF; PRPF3
607333 STE20-RELATED KINASE ADAPTOR BETA; STRADB
608374 HEMOJUVELIN
608626 STE20-RELATED KINASE ADAPTOR ALPHA; STRADA
609007 LEUCINE-RICH REPEAT KINASE 2; LRRK2
609065 MOVED TO 605714
610070 ASTER-ASSOCIATED PROTEIN
610562 ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12A; ZC3H12A
610765 ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE
610918 SELENOPROTEIN M
611020 MICRO RNA 21; MIR21
611087 POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE
612005 CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7
612144 MICRO RNA LET7C; MIRLET7C
612224 STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12
612713 KAHRIZI SYNDROME
612715 DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2
612733 THO COMPLEX 5; THOC5
612735 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-3; HLA-DRB3
612737 STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17
612739 SPERM ACROSOME-ASSOCIATED 1; SPACA1
612741 SNAIL, DROSOPHILA, HOMOLOG OF, 3; SNAI3
612742 MICRO RNA 181A1; MIR181A1
612743 MICRO RNA 181A2; MIR181A2
612744 MICRO RNA 181B1; MIR181B1
612745 MICRO RNA 181B2; MIR181B2
612746 MICRO RNA 181C; MIR181C
612747 TUFTELIN-INTERACTING PROTEIN 11; TFIP11
612748 LYSOZYME-LIKE 2; LYZL2
612749 SPERM ACROSOME-ASSOCIATED 3; SPACA3
612750 LYSOZYME-LIKE 4; LYZL4
612751 LYSOZYME-LIKE 6; LYZL6
612752 CXXC FINGER PROTEIN 5; CXXC5
612753 COLLAGEN AND CALCIUM-BINDING EGF DOMAIN-CONTAINING PROTEIN 1; CCBE1
612754 GLUTAREDOXIN 3; GLRX3
612755 MITOCHONDRIAL DISTRIBUTION AND MORPHOLOGY 20, YEAST, HOMOLOG OF
612756 TESTICULAR CELL ADHESION MOLECULE 1; TCAM1
612757 GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING
612758 TRANSMEMBRANE ANTERIOR POSTERIOR TRANSFORMATION 1; TAPT1
612759 SYNESTHESIA
612760 SNF-RELATED KINASE; SNRK
612761 SWI/SNF-RELATED, MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN,
612762 SUPPRESSOR OF TY 7-LIKE; SUPT7L
612763 TRANSCRIPTIONAL ADAPTOR 1-LIKE; TADA1L
612764 ISY1 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; ISY1
612765 SFI1, YEAST, HOMOLOG OF; SFI1
612766 CHROMOSOME 19 OPEN READING FRAME 62; C19ORF62

May 12, 2009

Changed Entries:

136760 FRONTONASAL DYSPLASIA
142340 DIAPHRAGMATIC HERNIA, CONGENITAL
142445 NEUREGULIN 1; NRG1
143100 HUNTINGTON DISEASE; HD
147141 TRANSCRIPTION FACTOR 3; TCF3
158000 MONILETHRIX
162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA
162641 NEUROPEPTIDE Y RECEPTOR Y1; NPY1R
179551 V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG B; RALB
180630 DEAD/H BOX 5; DDX5
191170 TUMOR PROTEIN p53; TP53
229400 FRONTOFACIONASAL DYSPLASIA
263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION
266600 INFLAMMATORY BOWEL DISEASE 1; IBD1
300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2
600142 CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS
600206 EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8; EPS8
600307 PROTEASOME SUBUNIT, BETA-TYPE, 6; PSMB6
600377 GALANIN RECEPTOR 1; GALR1
600543 V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 4; ERBB4
600849 NUCLEAR RECEPTOR COREPRESSOR 1; NCOR1
601928 KERATIN 86; KRT86
602194 HTRA SERINE PEPTIDASE 1; HTRA1
602559 EXPORTIN 1; XPO1
603030 TOLL-LIKE RECEPTOR 4; TLR4
603671 ACROMELIC FRONTONASAL DYSOSTOSIS
604061 SEPTIN 9; SEPT9
604261 AUTOPHAGY 5, S. CEREVISIAE, HOMOLOG OF; ATG5
604666 MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; MAP4K4
604798 HOMER, DROSOPHILA, HOMOLOG OF, 1; HOMER1
604799 HOMER, DROSOPHILA, HOMOLOG OF, 2; HOMER2
604800 HOMER, DROSOPHILA, HOMOLOG OF, 3; HOMER3
604834 TANK-BINDING KINASE 1; TBK1
604999 SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1
605101 MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7-INTERACTING PROTEIN
606152 SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 3; SLC19A3
606598 GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1
607831 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K
607902 RNA, U TRANSPORTER 1; RNUT1
610767 AUTOPHAGY 16-LIKE 1; ATG16L1
611081 INFLAMMATORY BOWEL DISEASE 10; IBD10
612278 INFLAMMATORY BOWEL DISEASE 19; IBD19

May 11, 2009

Changed Entries:

107730 APOLIPOPROTEIN B; APOB
120435 LYNCH SYNDROME I
128100 DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1
136760 FRONTONASAL DYSPLASIA
143100 HUNTINGTON DISEASE; HD
164210 HEMIFACIAL MICROSOMIA; HFM
164400 SPINOCEREBELLAR ATAXIA 1; SCA1
164730 V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1
171300 PHEOCHROMOCYTOMA
188550 THYROID CARCINOMA, PAPILLARY
191170 TUMOR PROTEIN p53; TP53
204500 CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2
220150 HYPOURICEMIA, RENAL, 1; RHUC1
229400 FRONTOFACIONASAL DYSOSTOSIS
300035 EPHRIN B1; EFNB1
300451 ECTODYSPLASIN A; EDA
305100 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, X-LINKED; XHED
305645 MOVED TO 136760
600825 RAR-RELATED ORPHAN RECEPTOR A; RORA
600974 DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7
601409 HIV-1 TAT-INTERACTING PROTEIN; HTATIP
601452 OCULOAURICULOFRONTONASAL SYNDROME; OAFNS
601556 ATAXIN 1; ATXN1
602421 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
603022 E4F TRANSCRIPTION FACTOR 1; E4F1
603671 ACROMELIC FRONTONASAL DYSOSTOSIS
604517 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA;
605646 SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
606705 DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36
606706 TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1
606725 CLN6 GENE; CLN6
607096 SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12; SLC22A12
607709 TIGHT JUNCTION PROTEIN 2; TJP2
607998 TRIPEPTIDYL PEPTIDASE I; TPP1
608102 CLN5 GENE; CLN5
608466 ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1; AHSA1
609310 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2
610558 MITOGEN-ACTIVATED PROTEIN KINASE-ASSOCIATED PROTEIN 1; MAPKAP1

May 8, 2009

Changed Entries:

118200 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B
119800 CLUBFOOT, CONGENITAL; CCF
126450 DOPAMINE RECEPTOR D2; DRD2
132811 EPOXIDE HYDROLASE 2, CYTOSOLIC; EPHX2
134350 COMPLEMENT FACTOR D; CFD
137168 GAMMA-GLUTAMYLTRANSFERASE 5; GGT5
137580 GILLES DE LA TOURETTE SYNDROME; GTS
139250 GROWTH HORMONE 1; GH1
143170 MALE-ENHANCED ANTIGEN 1; MEA1
159900 MYOCLONIC DYSTONIA
164280 FEINGOLD SYNDROME
172439 PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE; PAICS
174500 POLYDACTYLY, PREAXIAL II; PPD2
185440 SUPPRESSOR OF TUMORIGENICITY 2; ST2
191175 HEAT-SHOCK PROTEIN, 90-KD, BETA, 1; HSP90B1
200150 CHOREOACANTHOCYTOSIS; CHAC
204690 AMELOGENESIS IMPERFECTA, TYPE IG; AI1G
208900 ATAXIA-TELANGIECTASIA; AT
248510 MANNOSIDOSIS, BETA A, LYSOSOMAL
253270 HOLOCARBOXYLASE SYNTHETASE DEFICIENCY
262600 PITUITARY DWARFISM III
277000 MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME
300183 NONCOMPACTION OF LEFT VENTRICULAR MYOCARDIUM, FAMILIAL ISOLATED, X-LINKED;
300394 TAFAZZIN; TAZ
300624 FRAGILE X MENTAL RETARDATION SYNDROME
600921 FIBROBLAST GROWTH FACTOR 9; FGF9
600962 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK
601203 INTERLEUKIN 1 RECEPTOR-LIKE 1; IL1RL1
601367 STROKE, ISCHEMIC
601622 TWIST, DROSOPHILA, HOMOLOG OF, 1; TWIST1
601784 CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 1; ACCN1
601828 NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2
602149 PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PITX1
602671 SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER
602885 MOTILIN RECEPTOR; MLNR
603165 DERMATITIS, ATOPIC
604143 EXTRA SPINDLE POLES-LIKE 1; ESPL1
604590 Fc FRAGMENT OF IgG, LOW AFFINITY IIb, RECEPTOR FOR; FCGR2B
606904 EPILEPSY, JUVENILE MYOCLONIC; JME
607585 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
608094 SOLUTE CARRIER FAMILY 37 (GLYCEROL-3-PHOSPHATE TRANSPORTER), MEMBER
608863 PODOPLANIN; PDPN
609489 MANNOSIDASE, BETA A, LYSOSOMAL; MANBA
609702 PROTEASOME-ASSEMBLING CHAPERONE 2; PSMG2
612759 SYNESTHESIA

May 7, 2009

Changed Entries:

100300 ADAMS-OLIVER SYNDROME; AOS
102560 ACTIN, GAMMA-1; ACTG1
103285 ADULT SYNDROME
104300 ALZHEIMER DISEASE; AD
104760 AMYLOID BETA A4 PRECURSOR PROTEIN; APP
106260 ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE
112267 BONE MORPHOGENETIC PROTEIN 7; BMP7
114240 CALPAIN 3; CAPN3
119530 OROFACIAL CLEFT 1; OFC1
129400 RAPP-HODGKIN SYNDROME; RHS
129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME
131550 EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR
133430 ESTROGEN RECEPTOR 1; ESR1
135750 LAURIN-SANDROW SYNDROME
137575 GIGANTIFORM CEMENTOMA, FAMILIAL
139191 GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR
142940 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1; HMGCS1
143100 HUNTINGTON DISEASE; HD
150330 LAMIN A/C; LMNA
154750 MARFANOID HYPERMOBILITY SYNDROME
164730 V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1
165070 FMS-RELATED TYROSINE KINASE 1; FLT1
171834 PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA; PIK3CA
178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1
187380 TENASCIN C; TNC
188470 THYROID CARCINOMA, FOLLICULAR; FTC
188840 TITIN; TTN
189980 ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1
191170 TUMOR PROTEIN p53; TP53
194190 WOLF-HIRSCHHORN SYNDROME; WHS
217990 CORPUS CALLOSUM, AGENESIS OF
222448 DONNAI-BARROW SYNDROME
267000 RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM
600028 DISTAL-LESS HOMEOBOX 5; DLX5
600030 DISTAL-LESS HOMEOBOX 6; DLX6
600073 LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2
600234 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2; HMGCS2
600488 PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 5; PCSK5
600799 BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE II; BMPR2
600807 ASTHMA, SUSCEPTIBILITY TO
601517 ATAXIN 2; ATXN2
601691 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 4; ABCA4
602925 PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA; PIK3CB
603273 TUMOR PROTEIN p63; TP63
604292 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME
605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED
605911 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2 DEFICIENCY
605996 DOM3, C. ELEGANS, HOMOLOG OF, Z; DOM3Z
606409 ITCHY, MOUSE, HOMOLOG OF; ITCH
607642 RETINOIC ACID-INDUCED GENE 1; RAI1
608851 EXORIBONUCLEASE 2; XRN2
609065 MOVED TO 605714
609301 p53 EFFECTOR RELATED TO PMP22; PERP
611667 SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2; SPATS2
612289 PROGEROID SYNDROME, CONGENITAL, PETTY TYPE

May 6, 2009

New Entries:

612726 HARDIKAR SYNDROME
612778 SET DOMAIN-CONTAINING PROTEIN 2; SETD2

Changed Entries:

104300 ALZHEIMER DISEASE; AD
113730 UNCOUPLING PROTEIN 1; UCP1
123450 CRI-DU-CHAT SYNDROME
128230 DYSTONIA, DOPA-RESPONSIVE; DRD
138280 GLUTAMINASE, PHOSPHATE-ACTIVATED; GLS
142940 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1, SOLUBLE; HMGCS1
147791 JACOBSEN SYNDROME; JBS
151410 BREAKPOINT CLUSTER REGION; BCR
164210 HEMIFACIAL MICROSOMIA; HFM
170998 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
180849 RUBINSTEIN-TAYBI SYNDROME; RSTS
181510 SCHIZOPHRENIA 1; SCZD1
187430 CYSTEINE-RICH SECRETORY PROTEIN 2; CRISP2
190080 V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG; MYC
219250 CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC
222100 DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
252010 MITOCHONDRIAL COMPLEX I DEFICIENCY
255600 MYOSCLEROSIS, AUTOSOMAL RECESSIVE
276905 MOVED TO 605472
300300 BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
600234 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2, MITOCHONDRIAL; HMGCS2
600243 DEFENDER AGAINST CELL DEATH; DAD1
600531 SOLUTE CARRIER FAMILY 9, MEMBER 4; SLC9A4
600625 OROFACIAL CLEFT 11; OFC11
601500 SMOOTHENED, DROSOPHILA, HOMOLOG OF; SMOH
602150 SNAIL, DROSOPHILA, HOMOLOG OF, 2; SNAI2
602713 A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 9; ADAM9
603252 FORKHEAD BOX L1; FOXL1
605797 ANKYRIN REPEAT, SAM, AND BASIC LEUCINE ZIPPER DOMAIN-CONTAINING 1;
605854 BCL2-BINDING COMPONENT 3; BBC3
606365 GLUTAMINASE, LIVER; GLS2
607962 MICRO RNA 23A; MIRN23A
607982 SCY1-LIKE 1; SCYL1
608232 LEUKEMIA, CHRONIC MYELOID; CML
608367 MYOPIA 4; MYP4
609065 CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS, HEREDITARY, DUTCH TYPE; HCHWAD
610175 MICRO RNA 130A; MIR130A
610723 MICRO RNA 23B; MIRN23B
611512 JUMONJI DOMAIN-CONTAINING PROTEIN 1A; JMJD1A
612255 INFLAMMATORY BOWEL DISEASE 15; IBD15
612691 POLYMICROGYRIA, BILATERAL OCCIPITAL
612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL
612717 MYOPIA 15; MYP15
612718 ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY
612721 REGULATED ENDOCRINE-SPECIFIC PROTEIN 18
612722 ELONGATION PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; ELP3
612723 PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY H, MEMBER 2;
612724 ALDOLASE B, FRUCTOSE-BISPHOSPHATE; ALDOB
612727 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13
612728 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14
612729 LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1
612730 SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8; SLC9A8
612732 COPROPORPHYRINOGEN OXIDASE; CPOX
612734 TLX1 DIVERGENT GENE
612736 GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY
612738 SOLUTE CARRIER FAMILY 9, MEMBER 10; SLC9A10
Clinical Synopsis for 261600 PHENYLKETONURIA; PKU

May 5, 2009

Changed Entries:

104760 AMYLOID BETA A4 PRECURSOR PROTEIN; APP
108733 ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2; ATP2B2
109535 CD40 ANTIGEN; CD40
118504 CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
118507 CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2
120620 COMPLEMENT COMPONENT RECEPTOR 1; CR1
134370 COMPLEMENT FACTOR H; CFH
134371 COMPLEMENT FACTOR H-RELATED 1; CFHR1
146110 HYPOGONADOTROPIC HYPOGONADISM
146928 INTERLEUKIN 8 RECEPTOR, BETA; IL8RB
146930 INTERLEUKIN 8; IL8
152790 LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; LHCGR
159555 MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA GENE; MLL
162330 TACHYKININ 3; TAC3
162332 TACHYKININ RECEPTOR 3; TACR3
163730 NITRIC OXIDE SYNTHASE 2A; NOS2A
164177 POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1; POU5F1
170998 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
171834 PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA; PIK3CA
173350 PLASMINOGEN; PLG
176410 PRECOCIOUS PUBERTY, MALE-LIMITED
176640 PRION PROTEIN; PRNP
184429 SRY-BOX 2; SOX2
226650 EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE
261800 PIERRE ROBIN SYNDROME
266600 INFLAMMATORY BOWEL DISEASE 1; IBD1
306700 HEMOPHILIA A
600715 THROMBOSPONDIN IV; THBS4
600979 LYMPHOTOXIN B RECEPTOR; LTBR
601231 FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN 1; FRAP1
601386 DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12
601728 PHOSPHATASE AND TENSIN HOMOLOG; PTEN
601969 DELETED IN MALIGNANT BRAIN TUMORS 1; DMBT1
601974 SPHINGOSINE 1-PHOSPHATE RECEPTOR 1; S1PR1
602039 EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT A; EIF3A
602196 PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES
603172 UBIQUITIN-ACTIVATING ENZYME E1C; UBE1C
603385 NEDD8-ACTIVATING ENZYME E1, SUBUNIT 1; NAE1
603639 A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17; ADAM17
605111 SPHINGOSINE 1-PHOSPHATE RECEPTOR 2; S1PR2
606229 EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 2; EIF2C2
606241 DICER, DROSOPHILA, HOMOLOG OF, 1; DICER1
607537 MASTERMIND-LIKE 2; MAML2
607714 TNFAIP3-INTERACTING PROTEIN 1; TNIP1
607937 HOMEOBOX TRANSCRIPTION FACTOR NANOG; NANOG
608160 SRY-BOX 9; SOX9
608938 RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 1; RPS6KB1
610164 MICRO RNA 134; MIRN134
610945 MICRO RNA 296; MIRN296
612255 INFLAMMATORY BOWEL DISEASE 15; IBD15

May 4, 2009

New Entries:

612759 SYNESTHESIA

Changed Entries:

107910 CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
110700 BLOOD GROUP--DUFFY SYSTEM; FY
114480 BREAST CANCER
121011 GAP JUNCTION PROTEIN, BETA-2; GJB2
131320 GATA-BINDING PROTEIN 3; GATA3
131960 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP
134797 FIBRILLIN 1; FBN1
141850 HEMOGLOBIN--ALPHA LOCUS 2; HBA2
147265 INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1
163890 SYNUCLEIN, ALPHA; SNCA
165070 FMS-RELATED TYROSINE KINASE 1; FLT1
176930 COAGULATION FACTOR II; F2
179300 RADIOULNAR SYNOSTOSIS
180740 SMALL NUCLEAR RIBONUCLEOPROTEIN, 70-KD; SNRP70
181500 SCHIZOPHRENIA; SCZD
181510 SCHIZOPHRENIA 1; SCZD1
182900 SPHEROCYTOSIS, TYPE 1; SPH1
190300 TREMOR, HEREDITARY ESSENTIAL, 1; ETM1
223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL
223900 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
227400 FACTOR V DEFICIENCY
230800 GAUCHER DISEASE, TYPE I
235800 HISTIDINEMIA
243300 CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME
248500 MANNOSIDOSIS, ALPHA B, LYSOSOMAL
249800 REMOVED FROM DATABASE
253000 MORQUIO SYNDROME A
255100 MYOPATHY WITH ABNORMAL LIPID METABOLISM
267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED
300568 MICRO RNA 221; MIR221
300569 MICRO RNA 222; MIR222
310200 MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
600045 DNA DAMAGE-BINDING PROTEIN 1; DDB1
600285 EUKARYOTIC TRANSLATION TERMINATION FACTOR 1; ETF1
601045 CATENIN, DELTA-1; CTNND1
601282 PLECTIN 1; PLEC1
601510 SREBP CLEAVAGE-ACTIVATING PROTEIN; SCAP
601763 CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8
601769 VITAMIN D RECEPTOR; VDR
601772 H2A HISTONE FAMILY, MEMBER X; H2AFX
602629 DYSTONIA 6, TORSION; DYT6
602680 RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5
602732 RHO GTPase-ACTIVATING PROTEIN 1; ARHGAP1
602941 BREAST CANCER ANTIESTROGEN RESISTANCE 1; BCAR1
604578 ABSENT IN MELANOMA 2; AIM2
604906 SCHIZOPHRENIA 9; SCZD9
605053 TAR RNA-BINDING PROTEIN 2; TARBP2
605111 SPHINGOSINE 1-PHOSPHATE RECEPTOR 2; S1PR2
605146 SPHINGOSINE 1-PHOSPHATE RECEPTOR 5; S1PR5
606667 LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5; LGR5
606838 PYD AND CARD DOMAIN-CONTAINING PROTEIN; PYCARD
607272 NDC80, S. CEREVISIAE, HOMOLOG OF; NDC80
607408 D-AMINO ACID OXIDASE ACTIVATOR; DAOA
609520 THAP DOMAIN-CONTAINING PROTEIN 1; THAP1
609564 POLY(ADP-RIBOSE) POLYMERASE 10; PARP10
609791 LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6A; LRRN6A
610513 ATPase, TYPE 13A2; ATP13A2
610754 WINGS APART-LIKE PROTEIN, DROSOPHILA, HOMOLOG OF; WAPAL
612729 LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1
Clinical Synopsis for 249800 REMOVED FROM DATABASE

May 1, 2009

New Entries:

612775 CONE-ROD DYSTROPHY 9; CORD9
Clinical Synopsis for 612539 SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42
Clinical Synopsis for 612540 MYOPATHY, CONGENITAL, COMPTON-NORTH

Changed Entries:

111150 BLOOD GROUP--LUTHERAN INHIBITOR; INLU
120970 CONE-ROD DYSTROPHY 2; CORD2
125480 MAJOR AFFECTIVE DISORDER 1; MAFD1
238320 LEYDIG CELL HYPOPLASIA, TYPE I
274400 THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1
600465 ANKYRIN 3; ANK3
605446 RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1
607485 FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS;
608194 CONE-ROD DYSTROPHY 13; CORD13
612775 CONE-ROD DYSTROPHY 9; CORD9
Clinical Synopsis for 127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT
Clinical Synopsis for 243800 JOHANSON-BLIZZARD SYNDROME; JBS
Clinical Synopsis for 309500 RENPENNING SYNDROME 1; RENS1

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH